Brilinta® 90 mg Tablets for Acute Coronary Syndrome

Brilinta is a prescription antiplatelet tablet used to reduce clot-related events after a heart attack or unstable angina. This page explains what it treats, how to take it safely, and key safety facts. It also outlines ordering basics with US delivery from Canada and ways to compare options without insurance.

What Brilinta Is and How It Works

Brilinta® (ticagrelor) is an oral P2Y12 receptor inhibitor used with low-dose aspirin to help prevent blood clots that can cause heart attacks and strokes. It blocks platelet activation in a reversible way, which can reduce the chance of stent thrombosis and recurrent events after acute coronary syndrome (ACS). For a detailed overview, see Ticagrelor 90 Mg.

CanadianInsulin.com is a prescription referral platform. We verify prescriptions with your prescriber when required, and licensed Canadian pharmacies dispense your order.

People often search for Ticagrelor 90 mg online when looking for therapy information. The details below summarize labeled uses, dosing basics, safety, and access, so you can review essentials before talking with your healthcare professional.

Who It’s For

This medicine is indicated to reduce the risk of cardiovascular death, myocardial infarction, and stroke in adults with ACS, including ST-elevation and non–ST-elevation myocardial infarction and unstable angina. It is also used to lower event risk in adults with a history of myocardial infarction. Learn more about the condition at Acute Coronary Syndrome.

Do not use it if you have active pathological bleeding or a history of intracranial hemorrhage. It is not recommended in severe hepatic impairment. Use caution if you have a tendency to bleed, bradyarrhythmias without a pacemaker, or gout. Some patients receive Ticagrelor 90 mg tablets during the first year after an ACS event, alongside low-dose aspirin, as directed by a prescriber.

Dosage and Usage

Typical adult dosing for ACS starts with a 180 mg loading dose, then 90 mg twice daily during the first year. After one year post–myocardial infarction, many patients may continue at 60 mg twice daily if still indicated. Use with a maintenance dose of aspirin (commonly 75 to 100 mg daily) unless your prescriber advises otherwise. Always follow the approved label and your prescriber’s instructions.

Swallow tablets with water, with or without food. If needed, tablets can be crushed and mixed with water for immediate use, then refilled with water and swallowed to ensure the full dose is taken. Try to take doses at the same times each day. Do not stop the treatment without medical guidance, especially soon after a stent placement, as stopping suddenly may increase the risk of a cardiac event.

Strengths and Forms

This antiplatelet is supplied as film-coated tablets in commonly available strengths such as 60 mg and 90 mg. Pack sizes vary by pharmacy and market. Availability may differ by region and over time.

We carry Brilinta 90mg tablets as well as the 60 mg strength when available. Your prescriber will select the appropriate strength based on timing after ACS and your overall risk profile.

Missed Dose and Timing

If you miss a dose, take one dose as soon as you remember, then take the next dose at the regularly scheduled time. Do not take two doses at once. Keeping a steady routine and using reminders can help maintain adherence.

Storage and Travel Basics

Store tablets at room temperature as directed on the label. Keep the bottle tightly closed and protect it from excessive moisture. Use child-resistant containers and keep this medicine out of reach of children and pets. Do not store in the bathroom.

For travel, carry your medication in original packaging along with a copy of your prescription or medication list. Pack it in your carry-on to avoid extreme temperatures. Allow extra time for screening and keep doses accessible if you need to take one while in transit.

Benefits

This therapy helps reduce platelet clumping, which can lower the risk of recurrent heart attack, stroke, or stent thrombosis in indicated patients. The oral tablet format is straightforward for daily use. The reversible binding profile can support flexible management under a clinician’s supervision. Tablets can be administered whole or, if needed, crushed and mixed with water per labeling, which can aid those with swallowing difficulties.

Side Effects and Safety

• Shortness of breath
• Headache or dizziness
• Nausea or diarrhea
• Mild bleeding or bruising
• Heartburn

Serious bleeding can occur, including gastrointestinal or intracranial hemorrhage. Seek emergency care for signs of major bleeding, such as black stools, coughing up blood, unusual weakness, or severe headache. Rare events include significant bradyarrhythmias and hypersensitivity reactions. Bleeding risk may be higher when used with anticoagulants, NSAIDs, or other medicines that affect hemostasis. Always report new symptoms to your clinician.

Drug Interactions and Cautions

Avoid strong CYP3A inhibitors such as ketoconazole, clarithromycin, and ritonavir, and strong CYP3A inducers such as rifampin, carbamazepine, and phenytoin. Using these may change drug levels and effectiveness. Monitor when taking digoxin. Limit simvastatin or lovastatin to 40 mg daily if used together. Maintenance aspirin doses above 100 mg may reduce effectiveness.

Use caution with other agents that increase bleeding risk, including anticoagulants and chronic NSAID therapy. Discuss all prescription and nonprescription medicines, vitamins, and herbal products with your prescriber. For background on alternatives in this class, see Prasugrel 10 Mg.

What to Expect Over Time

Platelet inhibition begins after the loading dose and continues with regular twice-daily use. Many patients remain on therapy long-term after an ACS event, per label and prescriber direction. Consistent adherence, aspirin co-therapy as instructed, and regular follow-up are important. If you notice unusual bleeding, shortness of breath that worsens, or new symptoms, contact your healthcare professional promptly.

Compare With Alternatives

Your prescriber may consider the generic active ingredient Ticagrelor when appropriate. Other P2Y12 options include clopidogrel, available as Clopidogrel, and prasugrel. Selection depends on your cardiovascular history, procedural details, bleeding risk, drug interactions, and tolerability.

Pricing and Access

Canadian pricing is shown on the product page. You can review the Brilinta 90 mg price and compare it with generic options where available. If you are evaluating the Brilinta 90 mg cost versus ticagrelor, your prescriber can help decide which option aligns with your treatment goals. Items typically Ships from Canada to US, and checkout on our site is encrypted. You can also browse related options within Heart Health Medications.

Cash-pay totals vary by strength, pack size, and pharmacy dispensing. We do not quote amounts here; see the live listing for current figures and availability before you place an order.

Availability and Substitutions

Supply can vary by strength and pack size. If a specific presentation is unavailable, your prescriber may recommend the generic active ingredient or another P2Y12 inhibitor that suits your history. You may see Brilinta 90 mg online listed as the brand and ticagrelor as the generic. Any substitution requires a valid prescription and clinical approval.

Patient Suitability and Cost-Saving Tips

Adults who have recently had an ACS event or a prior myocardial infarction may be candidates if they do not have contraindications such as active bleeding or prior intracranial hemorrhage. Those with severe liver impairment, ongoing significant bleeding, or high aspirin maintenance doses may not be suitable. Dyspnea can occur; discuss symptoms with your clinician.

For affordability, ask your prescriber if a generic is appropriate. Consider multi-month fills when permitted, which can lower per-unit costs and reduce refill trips. Set reminders to avoid missed doses. Review your full medication list regularly to avoid interactions that could increase bleeding risk.

Questions to Ask Your Clinician

• Is this antiplatelet the right choice for my ACS history?
• How long should I stay on therapy after my stent procedure?
• What daily aspirin dose should I take with this medicine?
• Which signs of bleeding require urgent evaluation?
• Do any of my medicines interact with ticagrelor?
• Could a generic alternative meet my needs and reduce costs?

Authoritative Sources

AstraZeneca Brilinta Prescribing Information

FDA DailyMed

Health Canada Drug Product Database

Ready to proceed? Start your order at CanadianInsulin with prompt, express, temperature-controlled handling when required, and US shipping from Canada. This content is for general information only and does not replace the advice of your healthcare professional.